Frazier Financial Advisors’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.26K Hold
10
﹤0.01% 485
2026
Q1
$5.62K Hold
10
﹤0.01% 496
2025
Q4
$6.77K Hold
10
﹤0.01% 420
2025
Q3
$6.39K Hold
10
﹤0.01% 419
2025
Q2
$5.36K Hold
10
﹤0.01% 445
2025
Q1
$4.2K Hold
10
﹤0.01% 454
2024
Q4
$4.13K Hold
10
﹤0.01% 468
2024
Q3
$5.05K Hold
10
﹤0.01% 529
2024
Q2
$4.87K Hold
10
﹤0.01% 624
2024
Q1
$5.4K Hold
10
﹤0.01% 578
2023
Q4
$5.55K Buy
+10
New +$4.7K ﹤0.01% 471

Other funds holding IDXX

Frazier Financial Advisors's IDXX Position: Q2 2026 in Review

Frazier Financial Advisors held its Idexx Laboratories (IDXX) position steady in Q2 2026 at 10 shares worth $5.26K. The position accounts for ﹤0.01% of the portfolio, ranked #485.

Frazier Financial Advisors first reported a position in IDXX in Q4 2023 and has held it in 11 quarters since. The position peaked at $6.77K in Q4 2025. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Frazier Financial Advisors held 10 shares of Idexx Laboratories worth $5.26K as of Q2 2026.
  • Frazier Financial Advisors left its Idexx Laboratories share count unchanged in Q2 2026.
  • Idexx Laboratories made up ﹤0.01% of Frazier Financial Advisors's portfolio in Q2 2026, its #485 holding.
  • Frazier Financial Advisors first reported a position in Idexx Laboratories in Q4 2023 and has held it in 11 quarters since.
  • Frazier Financial Advisors's Idexx Laboratories position peaked at $6.77K in Q4 2025.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Frazier Financial Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.